Search JIM Advanced Search

Journal of Integrative Medicine ›› 2021, Vol. 19 ›› Issue (2): 111-119.doi: 10.1016/j.joim.2021.01.009

• Original Chinical Research • Previous Articles     Next Articles

Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial

Jie Wua, Shu-wei Duana, Hong-tao Yangb, Yue-yi Dengc, Wei Li d, Ya-ni He e, Zhao-hui Nif, Yong-li Zhang, Shan Linh, Zhi-yong Guoi, Jun Zhuj, Jing-ai Fang k, Xu-sheng Liul, Li-hua Wangm, Rong Wangn, Nian-song Wango, Xiao-hong Chengp, Li-qun Heq, Ping Luor, Shi-ren Suns, Ji-feng Sunt, Ai-ping Yinu, Geng-ru Jiangv, Hong-yu Chenw, Wen-hu Liux, Hong-li Liny, Meng Liangz, Lu Maaa, Ming Chenab, Li-qun Songac, Jian Chenad, Qing Zhuae, Chang-ying Xingaf, Yun Liag, Ji-ning Gaoah, Rong-shan Liai, Ying Liaj, Hao Zhangak, Ying Lual, Qiao-ling Zhouam, Jun-zhou Fuan, Qiang Heao, Guang-yan Caia, Xiang-mei Chenaa   

  1. a Department of Nephrology, Chinese People’s Liberation Army General Hospital, Chinese People’s Liberation Army Institute of Nephrology, State Key Laboratory of Kidney Diseases
    (2011DAV00088), National Clinical Research Center for Kidney Diseases, Beijing 100853, China
    b Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300192, China
    c Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
    d Department of Nephrology, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan 250011, Shandong Province, China
    e Department of Nephrology, Daping Hospital, Army Medical University, Chongqing 400042, China
    f Department of Nephrology, Renji Hospital, Shanghai Jiao Tong University, Shanghai 200127, China
    g Department of Nephrology, Guang’anmen Hospital, China Academy of Traditional Chinese Medical Sciences, Beijing 100053, China
    h Department of Nephrology, Tianjin Medical University General Hospital, Tianjin 300052, China
    i Department of Nephrology, Changhai Hospital of Shanghai, Naval Medical University, Shanghai 200433, China
    j Department of Nephrology, West China Hospital, Chengdu 610083, Sichuan Province, China
    k Department of Nephrology, First Affiliated Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
    l Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, Guangdong Province, China
    mDepartment of Nephrology, Shanxi Medical University Second Affiliated Hospital, Taiyuan 030001, Shanxi Province, China
    n Department of Nephrology, Shandong Provincial Hospital, Jinan 250021, Shandong Province, China
    o Department of Nephrology and Rheumatology, Affiliated Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
    p Department of Nephrology, Shaanxi Traditional Chinese Medicine Hospital, Xi’an 710003, Shaanxi Province, China
    q Department of Nephrology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China
    r Department of Nephrology, Jilin University Second Hospital, Changchun 130041, Jilin Province, China
    s Department of Nephrology, Xijing Hospital, Air Force Military Medical University, Xi’an 710032, Shaanxi Province, China
    t Department of Nephrology, Tangdu Hospital, Air Force Military Medical University, Xi’an 710038, Shaanxi Province, China
    u Department of Nephrology, the First Affiliated Hospital of Xi’an Jiao Tong University, Xi’an 710061, Shaanxi Province, China
    v Department of Nephrology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
    wDepartment of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou 310007, Zhejiang Province, China
    x Department of Nephrology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
    y Department of Nephrology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, Liaoning Province, China
    z Department of Nephrology, the 174th Hospital of the People’s Liberation Army, Xiamen 361003, Fujian Province, China
    aa Department of Nephrology, 281th Hospital of Chinese People’s Liberation Army, Qinhuangdao 066100, Hebei Province, China
    ab Department of Nephrology, Teaching Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, China
    ac Department of Nephrology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, Heilongjiang Province, China
    ad Department of Nephrology, 900th Hospital of the Joint Logistics Team of the Chinese People’s Liberation Army, Fuzhou 350001, Fujian Province, China
    ae Department of Nephrology, Henan Provincial People’s Hospital, Zhengzhou 450003, Henan Province, China
    af Department of Nephrology, Jiangsu Province Hospital, Nanjing 210029, Jiangsu Province, China
    ag Department of Nephrology, Jiangxi Provincial People’s Hospital, Nanchang 330006, Jiangxi Province, China
    ah Department of Nephrology, Shanxi Hospital of Integrated Traditional and Western Medicine, Taiyuan 030001, Shanxi Province, China
    ai Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan 030012, Shanxi Province, China
    aj Department of Nephrology, the Third Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei Province, China
    ak Department of Nephrology, the Third Xiangya Hospital of Central South University, Changsha 410000, Hunan Province, China
    al Department of Nephrology, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China
    am Department of Nephrology, Xiangya Hospital of Central South University, Changsha 410008, Hunan Province, China
    an Department of Nephrology, Guangzhou First People’s Hospital, Guangzhou 510180, Guangdong Province, China
    ao Department of Nephrology, Zhejiang Provincial People’s Hospital, Hangzhou 310014, Zhejiang Province, China
  • Received:2020-08-24 Accepted:2020-12-24 Online:2021-03-12 Published:2021-03-26

Shenyankangfu Tablet (SYKFT) is a Chinese patent medicine that has been used widely to decrease proteinuria and the progression of chronic kidney disease.

This trial compared the efficacy and safety of SYKFT, for the control of proteinuria in primary glomerulonephritis patients, against the standard drug, losartan potassium.

Design, setting, participants and intervention
This was a multicenter, double-blind, randomized, controlled clinical trial. Primary glomerulonephritis patients, aged 18–70 years, with blood pressure ≤ 140/90 mmHg, estimated glomerular filtration rate (eGFR) ≥ 45 mL/min per 1.73 m2, and 24-hour proteinuria level of 0.5–3.0 g, were recruited in 41 hospitals across 19 provinces in China and were randomly divided into five groups: SYKFT, losartan potassium 50 mg or 100 mg, SYKFT plus losartan potassium 50 mg or 100 mg.

Main outcome measures
The primary outcome was change in the 24-hour proteinuria level, after 48 weeks of treatment.

A total of 735 participants were enrolled. The percent decline of urine protein quantification in the SYKFT group after 48 weeks was 8.78% ± 2.56% (P = 0.006) more than that in the losartan 50 mg group, which was 0.51% ± 2.54% (P = 1.000) less than that in the losartan 100 mg group. Compared with the losartan potassium 50 mg group, the SYKFT plus losartan potassium 50 mg group had a 13.39% ± 2.49% (P < 0.001) greater reduction in urine protein level. Compared with the losartan potassium 100 mg group, the SYKFT plus losartan potassium 100 mg group had a 9.77% ± 2.52% (= 0.001) greater reduction in urine protein. With a superiority threshold of 15%, neither was statistically significant. eGFR, serum creatinine and serum albumin from the baseline did not change statistically significant. The average change in TCM syndrome score between the patients who took SYKFT (-3.00 [-6.00, -2.00]) and who did not take SYKFT (-2.00 [-5.00, 0]) was statistically significant (P = 0.003). No obvious adverse reactions were observed in any group.

SYKFT decreased the proteinuria and improved the TCM syndrome scores of primary glomerulonephritis patients, with no change in the rate of decrease in the eGFR. SYKFT plus losartan potassium therapy decreased proteinuria more than losartan potassium therapy alone.

Trial registration number
NCT02063100 on

Key words: Herbal medicine, Chinese, Shenyankangfu Tablet, Primary glomerulonephritis, Randomized controlled trial, Double blind, Double dummy

[1] Chiung-Hui Huang, Mei-Ling Yeh, Fang-Pey Chen, Daphne Wu. Low-level laser acupuncture reduces postoperative pain and morphine consumption in older patients with total knee arthroplasty: A randomized placebo-controlled trial. Journal of Integrative Medicine, 2022, 20(4): 321-328.
[2] Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[3] Ubiratan Cardinalli Adler, Maristela Schiabel Adler, Ana Elisa Madureira Padula, Livia Mitchiguian Hotta, Amarilysde Toledo Cesar, José Nelson Martins Diniz, Helen de Freitas Santos, Edson Zangiacomi Martinez. Homeopathy for COVID-19 in primary care: A randomized, double-blind, placebo-controlled trial (COVID-Simile study). Journal of Integrative Medicine, 2022, 20(3): 221-229.
[4] Xin Wang, Wen-juan Song, Yi Ruan, Bing-chu Li, Can Lü, Nian Huang, Fan-fu Fang, Wei Gu. Core muscle functional strength training for reducing the risk of low-back pain in military recruits: An open-label randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 145-152.
[5] Meng-zhu Zhao, Chen Zhao, Shuang-shuang Tu, Xu-xu Wei, Hong-cai Shang. Evaluating the methodology of studies conducted during the global COVID-19 pandemic: A systematic review of randomized controlled trials. Journal of Integrative Medicine, 2021, 19(4): 317-326.
[6] Si-chun Gu, Jie Zhou, Qing Ye, Can-xing Yuan. Pingchan granule for depressive symptoms in Parkinson’s disease: A randomized, double-blind, placebo-controlled trial. Journal of Integrative Medicine, 2021, 19(2): 120-128.
[7] Xian Wang, Xuan Yin, Xiu-tian Guo, Yan Wang, Wen-qi Jin, Ai-jun Mao, Lixing Lao, Zhang-jin Zhang, Jie Zhang, Shi-fen Xu. Effects of the pestle needle therapy, a type of acupoint stimulation, on post-hemorrhoidectomy pain: A randomized controlled trial. Journal of Integrative Medicine, 2020, 18(6): 492-498.
[8] Sherman Gu, Arthur Yin Fan. Controversial conclusions from two randomized controlled trials for acupuncture's effects on polycystic ovary syndrome or in vitro fertilization support. Journal of Integrative Medicine, 2020, 18(2): 89-91.
[9] Gerli E.G. Herr, Fábio Goulart da Silva, Francisco José Cidral-Filho, Fabricia Petronilho, Lucinéia Gainski Danielski, Mariana Pereira de Souza Goldim, Afonso Shiguemi Inoue Salgado, Franciane Bobinski, Daniel Fernandes Martins, Eliane R. Winkelmann. Effects of the use of bioceramic wraps in patients with lower limb venous ulcers: A randomized double-blind placebo-controlled trial. Journal of Integrative Medicine, 2020, 18(1): 27-.
[10] Xin-yu Yue, Zhuo-qi Feng, Xi-yi Yu, Jia-min Hu, Xiao-Jing He, Shi Shu. Fire-needle acupuncture for upper limb spastic paralysis after stroke: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 167-172.
[11] Pádraic J.Dunne, Julie Lynch, Lucia Prihodova, Caoimhe O'Leary, Atiyeh Ghoreyshi, Sharee A. Basdeo, Donal J.Cox, Rachel Breen, Ali Sheikhi, Áine Carroll, Cathal Walsh, Geraldine McMahon, Barry White. Burnout in the emergency department: Randomized controlled trial of an attention-based training program. Journal of Integrative Medicine, 2019, 17(3): 173-180.
[12] Ya-ru Huangfu, Wei Peng, Bao-jun Guo, Zhi-fu Shen, Li Li, Shi-wei, Liu, Hui Zheng, You-ping Hu. Effects of acupuncture in treating insomnia due to spleen-stomach disharmony syndrome and its influence on intestinal microbiome: Study protocol for a randomized controlled trial. Journal of Integrative Medicine, 2019, 17(3): 161-167.
[13] J.M. Oliver-Baxter, H.S. Whitford, D.A. Turnbull, M.J. Bond. Effects of vitamin supplementation on inflammatory markers and psychological wellbeing among distressed women: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(5): 322-328.
[14] Parunkul Tungsukruthai, Preecha Nootim, Wiwan Worakunphanich, Nareerat Tabtong. Efficacy and safety of herbal steam bath in allergic rhinitis: A randomized controlled trial. Journal of Integrative Medicine, 2018, 16(1): 39-44.
[15] Zahra Hajmohammadi, Mojtaba Heydari, Majid Nimrouzi, Pouya Faridi, Mohammad Javad Zibaeenezhad, Gholamhossein Ranjbar Omrani, Mesbah Shams . Rhus coriaria L. increases serum apolipoprotein-A1 and high-density lipoprotein cholesterol levels: A double-blind placebo-controlled randomized clinical trial. Journal of Integrative Medicine, 2018, 16(1): 45-50.
Full text



[1] Fu-rong Du , Bin Zhang. Study on English translation for rhetoric devices in Neijing; intertextuality and synecdoche. Journal of Chinese Integrative Medicine, 2010, 8(12): 1207-1210
[2] Mei-jun Lü, Hui-yong Zhang, Zhe Zhang, Guan-lin Yang. Measurement of health-related quality of life in coronary heart disease: A review. Journal of Chinese Integrative Medicine, 2011, 9(12): 1277-1285
[3] Hua-fa Que, Han-jun Tang, Lin-yang Wang, Hong-yu Dai, Shi-yun Zhang, Hai-guang Qin, Xiao-dong Liu, Huan-yu Xiang, Zhen Zhang. Study on wound healing mechanism of replenishing qi and dissipating stagnation therapy for chronic skin ulcers. Journal of Chinese Integrative Medicine, 2005, 3(3): 243-246
[4] Wen-hui Ma, Xiao-hong Sun. Discussion of time and space differentiation of three-yin and three-yang in Shanghan Lun. Journal of Chinese Integrative Medicine, 2005, 3(4): 257-259
[5] Dong Yang, Shi Jian-rong. Biological research evaluating the Chinese medical theory of the association of the kidney with the ears. Journal of Chinese Integrative Medicine, 2012, 10(2): 128-134
[6] Xiao-hui Sun, Sheng Liu . External Chinese medical therapy for pain associated with hyperplastic disease of the breast: Study protocol of a randomized, double-blind, multicenter, controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(4): 384-389
[7] Hai-bo Yu, Cheng-en Pan, Wu-jun Wu, Si-hai Zhao, Hui-feng Zhang. Effects of resveratrol on matrix metalloproteinase-9 expression in hepatoma cells. Journal of Chinese Integrative Medicine, 2008, 6(3): 270-273
[8] Xiao-long Wei, Rui Feng, Zhi-qing Zhao, Zai-ping Jing. Efficacy of Chinese herbal medicine Mailuo Shutong Granule and Hirudoid cream for chronic venous disorder-induced pigmentation in lower extremities: A prospective, randomized controlled trial. Journal of Chinese Integrative Medicine, 2011, 9(8): 866-870
[9] Hui Han , Li-min Wu , Ming-xiang Han, Wen-ming Yang , Dao-jun Xie , Zhao-hui Fang , Dan-chen Chu , Fang Fang . Effects of Chinese herbal medicine Shenxiong Yujing Granule on regeneration of neural cells in rats with diabetes-associated cerebral ischemia. Journal of Chinese Integrative Medicine, 2012, 10(10): 1140-1148
[10] ZG Li. Comparative study on WHO Western Pacific Region and World Federation of Chinese Medicine Societies international standard terminologies on traditional medicine: An analysis of the Causes of Diseases (Part 2). Journal of Chinese Integrative Medicine, 2009, 7(4): 383-388